JULIO CESAR DELGADO

Summary

Affiliation: University of Utah
Country: USA

Publications

  1. doi request reprint Positive B-cell only flow cytometric crossmatch: implications for renal transplantation
    Julio C Delgado
    Division of Clinical Pathology, Department of Pathology, University of Utah School of Medicine, 15 North Medical Drive East, Salt Lake City, UT 84112, USA
    Exp Mol Pathol 85:59-63. 2008
  2. doi request reprint Identification of naturally processed ligands in the C57BL/6 mouse using large-scale mass spectrometric peptide sequencing and bioinformatics prediction
    Julio C Delgado
    Department of Pathology, University of Utah, 15 N Medical Drive East, Salt Lake City, UT 84112, USA
    Immunogenetics 61:241-6. 2009
  3. doi request reprint No occurrence of de novo HLA antibodies in patients with early corticosteroid withdrawal in a 5-year prospective randomized study
    Julio C Delgado
    Department of Pathology, University of Utah, Salt Lake City, UT, USA
    Transplantation 87:546-8. 2009
  4. doi request reprint Post-transplant increased levels of serum sCD30 is a marker for prediction of kidney allograft loss in a 5-year prospective study
    Julio C Delgado
    Department of Pathology, ARUP Institute for Clinical and Experimental Pathology, University of Utah, Salt Lake City, UT 84108, United States
    Transpl Immunol 22:1-4. 2009
  5. doi request reprint Utility of virtual crossmatch in sensitized patients awaiting heart transplantation
    Josef Stehlik
    U T A H Cardiac Transplant Program, University of Utah Hospital, and VA Salt Lake City Health Care System Cardiology Section, 500 Foothill Blvd, Salt Lake City, UT 84148, USA
    J Heart Lung Transplant 28:1129-34. 2009
  6. doi request reprint Binding of anti-HLA class I antibody to endothelial cells produce an inflammatory cytokine secretory pattern
    Eduardo Reyes-Vargas
    Department of Pathology, University of Utah, Salt Lake City, Utah 84112, USA
    J Clin Lab Anal 23:157-60. 2009
  7. ncbi request reprint Large scale mass spectrometric profiling of peptides eluted from HLA molecules reveals N-terminal-extended peptide motifs
    Hernando Escobar
    Department of Pathology, University of Utah, Salt Lake City, UT 84112, USA
    J Immunol 181:4874-82. 2008
  8. pmc Development and validation of a fluorescent microsphere immunoassay for soluble CD30 testing
    Igor Pavlov
    ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT 84108, USA
    Clin Vaccine Immunol 16:1327-31. 2009

Research Grants

Detail Information

Publications8

  1. doi request reprint Positive B-cell only flow cytometric crossmatch: implications for renal transplantation
    Julio C Delgado
    Division of Clinical Pathology, Department of Pathology, University of Utah School of Medicine, 15 North Medical Drive East, Salt Lake City, UT 84112, USA
    Exp Mol Pathol 85:59-63. 2008
    ..In this review we discuss several factors to consider during the evaluation of patients with a B+FCXM and suggest ideas to improve the use of the information provided by the FCXM assay...
  2. doi request reprint Identification of naturally processed ligands in the C57BL/6 mouse using large-scale mass spectrometric peptide sequencing and bioinformatics prediction
    Julio C Delgado
    Department of Pathology, University of Utah, 15 N Medical Drive East, Salt Lake City, UT 84112, USA
    Immunogenetics 61:241-6. 2009
    ..These results suggest that bioinformatics tools are reliable and efficient methods for binding prediction of naturally processed MHC class I ligands...
  3. doi request reprint No occurrence of de novo HLA antibodies in patients with early corticosteroid withdrawal in a 5-year prospective randomized study
    Julio C Delgado
    Department of Pathology, University of Utah, Salt Lake City, UT, USA
    Transplantation 87:546-8. 2009
    ..We conclude that renal transplant recipients on steroid withdrawal by the end of week 1 are not at higher risk for developing HLA antibodies compared with a standard steroid regimen up to 5 years posttransplant...
  4. doi request reprint Post-transplant increased levels of serum sCD30 is a marker for prediction of kidney allograft loss in a 5-year prospective study
    Julio C Delgado
    Department of Pathology, ARUP Institute for Clinical and Experimental Pathology, University of Utah, Salt Lake City, UT 84108, United States
    Transpl Immunol 22:1-4. 2009
    ..Levels of sCD30 represent a biomarker for early outcome in kidney transplantation. The purpose of this study was to determine the role of sCD30 levels for prediction of graft loss in the late post-transplant period...
  5. doi request reprint Utility of virtual crossmatch in sensitized patients awaiting heart transplantation
    Josef Stehlik
    U T A H Cardiac Transplant Program, University of Utah Hospital, and VA Salt Lake City Health Care System Cardiology Section, 500 Foothill Blvd, Salt Lake City, UT 84148, USA
    J Heart Lung Transplant 28:1129-34. 2009
    ..This study examined the accuracy of virtual crossmatch, in which recipient HLA-specific antibodies, identified by solid-phase assays, are compared to the prospective donor HLA-type in heart transplantation...
  6. doi request reprint Binding of anti-HLA class I antibody to endothelial cells produce an inflammatory cytokine secretory pattern
    Eduardo Reyes-Vargas
    Department of Pathology, University of Utah, Salt Lake City, Utah 84112, USA
    J Clin Lab Anal 23:157-60. 2009
    ....
  7. ncbi request reprint Large scale mass spectrometric profiling of peptides eluted from HLA molecules reveals N-terminal-extended peptide motifs
    Hernando Escobar
    Department of Pathology, University of Utah, Salt Lake City, UT 84112, USA
    J Immunol 181:4874-82. 2008
    ..In addition, these results expand the knowledge about the identity of anchor positions in HLA class I-associated peptides that can be used for characterization of HLA class I motifs...
  8. pmc Development and validation of a fluorescent microsphere immunoassay for soluble CD30 testing
    Igor Pavlov
    ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT 84108, USA
    Clin Vaccine Immunol 16:1327-31. 2009
    ....

Research Grants1

  1. Genetic/Immunological Basis of Tuberculosis and Anergy
    Julio Delgado; Fiscal Year: 2005
    ..It is anticipated that these results will be useful in the development of genetic and immune therapeutic strategies to combat tuberculosis. ..